Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1
Authors:
- Z. ZujovicZZZ. Zujovic
- G. BowmakerGBG. Bowmaker
- T. RadesT. Rades
- D. SavilleDSD. Saville
- 1 December 2006
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 327 (1-2) , 36-44
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric formsInternational Journal of Pharmaceutics, 2004
- Improving the filterability and solid density of ranitidine hydrochloride form 1Journal of Pharmaceutical Sciences, 2004
- Characterization of tautomeric forms of ranitidine hydrochloride: thermal analysis, solid-state NMR, X-rayJournal of Crystal Growth, 2003
- Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysisEuropean Journal of Pharmaceutics and Biopharmaceutics, 2002
- Determination of polymorphic forms of ranitidine–HCl by DRIFTS and XRPDJournal of Pharmaceutical and Biomedical Analysis, 2001
- Crystalline solidsAdvanced Drug Delivery Reviews, 2001
- Pharmaceutical Solids: A Strategic Approach to Regulatory ConsiderationsPharmaceutical Research, 1995
- Isoenergetic PolymorphsDrug Development and Industrial Pharmacy, 1995
- Structure of ranitidine hydrochlorideActa Crystallographica Section C Crystal Structure Communications, 1990
- Structure of a new H2-receptor antagonist, 2-(2-{[5-(dimethylammoniomethyl)-2-furyl]methylthio}ethylamino)-2-methylamino-1-nitroethylene hydrogen oxalate (ranitidine hydrogen oxalate)Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1982